Biomemory

Biomemory provides bio-digital data storage solutions, developing a petrol-free DNA synthesis and copy process based on synthetic biology for long-term data storage. The platform enables the production of long, bio-sourced, biocompatible, and bio-secure DNA fragments that can be stored as inert polymers for thousands of years without any energy input. Founded in 2021 and headquartered in Paris, France, Biomemory has raised approximately $23.2M in Series A funding from investors including eureKARE, Credit Mutuel Innovation, Bpifrance, Next Sequence, Sorbonne Venture, and Accelerem. The company employs 77 people and addresses the growing challenge of sustainable long-term data archiving by encoding digital information into synthetic DNA molecules, offering storage density and durability orders of magnitude beyond conventional magnetic and optical media while eliminating the energy costs associated with maintaining data center archives.